Aytu Biopharma, Inc.

Aytu BioPharma Inc. is a specialty pharmaceutical company dedicated to developing and commercializing innovative prescription therapeutics, with a particular emphasis on pediatric and pediatric-onset conditions. The company's diversified portfolio features treatments for attention deficit-hyperactivity disorder (ADHD), allergies, and fluoride deficiency, targeting prevalent and often underserved areas in patient care. Aytu BioPharma stands out for its patient-centric approach, exemplified by comprehensive support programs like Aytu RxConnect, which facilitate best-in-class patient access to therapies. The company’s growth strategy combines organic development with strategic in-licensing and acquisitions, regularly seeking new products that meet unmet needs or improve upon existing standards of care. Aytu BioPharma’s commercial operations and infrastructure support both prescription and consumer health segments, making it a notable contributor to advancing patient wellness in the broader pharmaceutical landscape.